Abstract

Oxandrolone 1-mg/mL Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2011 - Volume 15, Number 4

Page(s): 341

Download in electronic PDF format for $75

Abstract

A formulation for preparing Oxandrolone 1-mg/mL Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2011 Pg. 341	Oxandrolone 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 410	Oxandrolone 3 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2011 Pg. 505	Oxandrolone 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 394-395	Calculations: Evaluation of Body Weight and Units of Activity Author(s): Stockton Shelly J
May/Jun 2017 Pg. 255-263	Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions Author(s): de Oliveira Ferreira Anderson, Polonini Hudson C, Loures da Silva Sharlene, Cerqueira de Melo Victor Augusto, de Andrade Laura, Fernandes Brandão Marcos Antônio
Sep/Oct 2021 Pg. 416	Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2004 Pg. 10-14	Women's Oral Health: Is There a Hormonal Link? Author(s): Preckshot John
May/Jun 2010 Pg. 200-203	Topical Medications for Orofacial Neuropathic Pain Author(s): Bramwell Bethany L
Mar/Apr 2024 Pg. 100-109	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Mar/Apr 2014 Pg. 131-134	Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 182-192	Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
Sep/Oct 2023 Pg. 420	Nitazoxanide 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2025 Pg. 52-63	Compounded Tirzepatide Therapy for Weight Loss: A Health Economics & Outcomes Research (HEOR) Analysis Author(s): Guth Michael AS
Jul/Aug 2025 Pg. 267-278	Legal Challenges to Compounding Drugs for Weight Loss Author(s): Combs Blinn E, Howard Brad
May/Jun 2010 Pg. 257-260	Weight Uniformity of Scored Tablet Halves Manufactured by Palestinian Pharmaceutical Companies Author(s): Zaid AN, Abu Ghosh A, Kittana N
Jul/Aug 2009 Pg. 340	Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 291-292	Innovations in Compounding: Integrated Barcode System Verifies Chemical Identity, Weight Author(s): Vail Jane